Found: 25
Select item for more details and to access through your institution.
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update.
- Published in:
- Wiener Klinische Wochenschrift, 2022, v. 134, n. 19/20, p. 683, doi. 10.1007/s00508-022-02082-3
- By:
- Publication type:
- Article
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.
- Published in:
- Wiener Klinische Wochenschrift, 2022, v. 134, n. 1/2, p. 63, doi. 10.1007/s00508-021-01987-9
- By:
- Publication type:
- Article
Impact of Her-2-Targeted Therapy on Overall Survival in Patients With Her-2 Positive Metastatic Breast Cancer.
- Published in:
- Breast Journal, 2013, v. 19, n. 2, p. 149, doi. 10.1111/tbj.12070
- By:
- Publication type:
- Article
Extravasation of Pt-based chemotherapeutics – bioimaging of their distribution in resectates using laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS).
- Published in:
- Metallomics, 2015, v. 7, n. 3, p. 508, doi. 10.1039/c4mt00308j
- By:
- Publication type:
- Article
Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 7, doi. 10.1186/1472-6904-7-7
- By:
- Publication type:
- Article
Preoperative second-line chemotherapy induces objective responses in primary breast cancer.
- Published in:
- Wiener Klinische Wochenschrift, 2005, v. 117, n. 1/2, p. 48, doi. 10.1007/s00508-004-0282-y
- By:
- Publication type:
- Article
Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 155, doi. 10.1007/s00280-002-0476-9
- By:
- Publication type:
- Article
Indocyanine Green Video Angiography Predicts Outcome of Extravasation Injuries.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0103649
- By:
- Publication type:
- Article
Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2004, v. 130, n. 7, p. 400, doi. 10.1007/S00432-004-0559-6
- By:
- Publication type:
- Article
Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer.
- Published in:
- European Journal of Clinical Investigation, 2013, v. 43, n. 3, p. 286, doi. 10.1111/eci.12043
- By:
- Publication type:
- Article
Temporary Placement of Self-Expanding Oesophageal Stents as Bridging for Neo-Adjuvant Therapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 2, p. 470, doi. 10.1245/s10434-009-0760-6
- By:
- Publication type:
- Article
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment.
- Published in:
- BMC Cancer, 2006, v. 6, p. 81, doi. 10.1186/1471-2407-6-81
- By:
- Publication type:
- Article
Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational study.
- Published in:
- BMC Cancer, 2006, v. 6, p. 63, doi. 10.1186/1471-2407-6-63
- By:
- Publication type:
- Article
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 115, n. 2, p. 373, doi. 10.1007/s10549-008-0132-0
- By:
- Publication type:
- Article
Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel  G-CSF.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 104, n. 1, p. 109, doi. 10.1007/s10549-006-9397-3
- By:
- Publication type:
- Article
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 103, n. 1, p. 45, doi. 10.1007/s10549-006-9325-6
- By:
- Publication type:
- Article
Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 102, n. 3, p. 375, doi. 10.1007/s10549-006-9342-5
- By:
- Publication type:
- Article
Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 6, p. 1741, doi. 10.1007/s00520-014-2535-2
- By:
- Publication type:
- Article
Tissue distribution of epirubicin after severe extravasation in humans.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 203, doi. 10.1007/s00280-021-04280-8
- By:
- Publication type:
- Article
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 903, doi. 10.1007/s00280-008-0682-1
- By:
- Publication type:
- Article
Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 5, p. 554, doi. 10.1007/s00280-005-0092-6
- By:
- Publication type:
- Article
Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer.
- Published in:
- Journal of Neuro-Oncology, 2007, v. 85, n. 3, p. 311, doi. 10.1007/s11060-007-9420-5
- By:
- Publication type:
- Article
• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed—mutation rate of the marker higher than expected.
- Published in:
- European Surgery: ACA Acta Chirurgica Austriaca, 2018, v. 50, n. 4, p. 160, doi. 10.1007/s10353-018-0527-z
- By:
- Publication type:
- Article
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer.
- Published in:
- Breast Care, 2010, v. 5, n. 3, p. 158, doi. 10.1159/000314214
- By:
- Publication type:
- Article
Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect Ratio.
- Published in:
- Breast Care, 2009, v. 4, n. 3, p. 155, doi. 10.1159/000227829
- By:
- Publication type:
- Article